Filing Date: 2002-04-18. -- Priority Data: ES P 200100909 (2001-04-19)The invention relates to the use of the olfactory ensheathing glia produced using telomerase or the use of any molecule or molecules produced by the latter, either alone or combined with other reparative strategies, in order to treat nervous system lesions in mammals, including primates.Peer reviewed